| Year |
Citation |
Score |
| 2019 |
Jamieson C, Jiang Q, Holm F, Isquith J, Mark A, Mason C, Ma W, Diep RH, Pham J, Reynoso Moreno E, Nasamran CA, Guorong X, Birmingham A, Crews LA, Alexandrov L, et al. Inflammatory Cytokine Responsive Enzymatic Mutagenesis Fuels Myeloproliferative Neoplasm Pre-Leukemia Stem Cell Evolution Blood. 134: 3780-3780. DOI: 10.1182/Blood-2019-131510 |
0.304 |
|
| 2018 |
Crews LA, Lazzari E, Mondala PK, Santos ND, Miller A, Pineda G, Jiang Q, Ganesan A, Wu C, Costello C, Minden M, Chiaramonte R, Stewart AK, Jamieson CHM. Abstract 4437: Down-modulation of ADAR1-mediated GLI1 editing alters extracellular and immune response genes in multiple myeloma Cancer Research. 78: 4437-4437. DOI: 10.1158/1538-7445.Am2018-4437 |
0.307 |
|
| 2017 |
Lazzari E, Santos ND, Wu C, Leu H, Pineda G, Ali S, Costello C, Minden M, Chiaramonte R, Crews L, Jamieson C. Abstract 3351: Aberrant RNA editing of GLI1 promotes malignant regeneration in multiple myeloma Cancer Research. 77: 3351-3351. DOI: 10.1158/1538-7445.Am2017-3351 |
0.308 |
|
| 2016 |
Zipeto MA, Court AC, Sadarangani A, Delos Santos NP, Balaian L, Chun HJ, Pineda G, Morris SR, Mason CN, Geron I, Barrett C, Goff DJ, Wall R, Pellecchia M, Minden M, ... ... Crews LA, et al. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell Stem Cell. PMID 27292188 DOI: 10.1016/J.Stem.2016.05.004 |
0.314 |
|
| 2016 |
Lazzari E, Crews LA, Wu C, Leu H, Ali S, Chiaramonte R, Minden M, Costello C, Jamieson CHM. Abstract 2414: ADAR1-dependent RNA editing is a mechanism of therapeutic resistance in human plasma cell malignancies Cancer Research. 76: 2414-2414. DOI: 10.1158/1538-7445.Am2016-2414 |
0.314 |
|
| 2015 |
Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Current Hiv Research. 13: 43-54. PMID 25760044 DOI: 10.2174/1570162X13666150311164201 |
0.49 |
|
| 2015 |
Crews LA, Balaian L, Leu H, Delos Santos N, Court AC, Sadarangani A, Zipeto MA, La Clair JJ, Villa R, Morris S, Storb RF, Kulidjian A, Ball ED, Burkart MD, Jamieson C. RNA Splicing Modulation Impairs Acute Myeloid Leukemia Stem Cell Maintenance Blood. 126: 567-567. DOI: 10.1182/Blood.V126.23.567.567 |
0.328 |
|
| 2015 |
Lazzari E, Crews LA, Wu C, Leu H, Chiaramonte R, Minden MD, Costello CL, Jamieson C. Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor Blood. 126: 5351-5351. DOI: 10.1182/Blood.V126.23.5351.5351 |
0.302 |
|
| 2015 |
Zipeto MA, Court Recart A, Delos Santos N, Jiang Q, Crews LA, Jamieson CH. Inflammatory Cytokine-Responsive ADAR1 Impairs Let-7 Biogenesis and Promotes Leukemia Stem Cell Generation Blood. 126: 4014-4014. DOI: 10.1182/Blood.V126.23.4014.4014 |
0.3 |
|
| 2014 |
Wrasidlo W, Crews LA, Tsigelny IF, Stocking E, Kouznetsova VL, Price D, Paulino A, Gonzales T, Overk CR, Patrick C, Rockenstein E, Masliah E. Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders. British Journal of Pharmacology. 171: 5757-73. PMID 25117211 DOI: 10.1111/Bph.12875 |
0.434 |
|
| 2014 |
Zipeto MA, Jiang Q, Crews LA, Court Recart A, Jamieson CH. Regulation of Self-Renewal through Modulation of Let-7 Stem Cell Regulatory Family of microRNAs in Chronic Myeloid Leukemia Stem Cells Blood. 124: 4527-4527. DOI: 10.1182/Blood.V124.21.4527.4527 |
0.31 |
|
| 2014 |
Lazzari E, Crews LA, Zipeto MA, Ali S, Jamieson CH. Tracking Human Myeloma Cell Therapeutic Resistance Using a Novel Diagnostic Assay for Detection of RNA Editing Biomarkers of Cancer Stem Cell Generation Blood. 124: 3406-3406. DOI: 10.1182/Blood.V124.21.3406.3406 |
0.301 |
|
| 2014 |
Jiang Q, Zipeto M, Cournt A, Leu H, Crews L, Morris S, Jamieson C. Abstract 5103: RNA editing enzyme induces accelerated cell cycle in normal hematopoiesis Cancer Research. 74: 5103-5103. DOI: 10.1158/1538-7445.Am2014-5103 |
0.323 |
|
| 2013 |
Jiang Q, Crews LA, Barrett CL, Chun HJ, Court AC, Isquith JM, Zipeto MA, Goff DJ, Minden M, Sadarangani A, Rusert JM, Dao KH, Morris SR, Goldstein LS, Marra MA, et al. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 110: 1041-6. PMID 23275297 DOI: 10.1073/Pnas.1213021110 |
0.304 |
|
| 2013 |
Crews LA, Jamieson CH. Selective elimination of leukemia stem cells: hitting a moving target. Cancer Letters. 338: 15-22. PMID 22906415 DOI: 10.1016/J.Canlet.2012.08.006 |
0.311 |
|
| 2012 |
Desplats P, Spencer B, Crews L, Pathel P, Morvinski-Friedmann D, Kosberg K, Roberts S, Patrick C, Winner B, Winkler J, Masliah E. α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1. The Journal of Biological Chemistry. 287: 31691-702. PMID 22833673 DOI: 10.1074/Jbc.M112.354522 |
0.486 |
|
| 2012 |
Tsigelny IF, Sharikov Y, Wrasidlo W, Gonzalez T, Desplats PA, Crews L, Spencer B, Masliah E. Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation. The Febs Journal. 279: 1000-13. PMID 22251432 DOI: 10.1111/J.1742-4658.2012.08489.X |
0.433 |
|
| 2012 |
Jiang Q, Leu H, Shih A, Goff D, Court-Recart A, Ma W, Smith K, Sadarangani A, Geron I, Barrett C, Frazer KA, Crews LA, Jamieson CHm. Abstract 5217: RNA editing enzyme ADAR1 drives leukemia stem cell differentiation and self-renewal in chronic myeloid leukemia Cancer Research. 72: 5217-5217. DOI: 10.1158/1538-7445.Am2012-5217 |
0.332 |
|
| 2012 |
Ubhi K, Crews L, Masliah E. Alpha-Synuclein and Neurodegeneration Primer On the Autonomic Nervous System. 303-305. DOI: 10.1016/B978-0-12-386525-0.00063-9 |
0.386 |
|
| 2011 |
Crews L, Ruf R, Patrick C, Dumaop W, Trejo-Morales M, Achim CL, Rockenstein E, Masliah E. Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders. Molecular Neurodegeneration. 6: 67. PMID 21943307 DOI: 10.1186/1750-1326-6-67 |
0.5 |
|
| 2011 |
Rockenstein E, Ubhi K, Doppler E, Novak P, Moessler H, Li B, Blanchard J, Grundke-Iqbal I, Iqbal K, Mante M, Adame A, Crews L, Masliah E. Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice. Journal of Alzheimer's Disease : Jad. 27: 743-52. PMID 21860085 DOI: 10.3233/Jad-2011-110914 |
0.465 |
|
| 2011 |
Paulino AD, Ubhi K, Rockenstein E, Adame A, Crews L, Letendre S, Ellis R, Everall IP, Grant I, Masliah E. Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. Journal of Neurovirology. 17: 327-40. PMID 21660601 DOI: 10.1007/S13365-011-0039-0 |
0.419 |
|
| 2011 |
Masliah E, Rockenstein E, Mante M, Crews L, Spencer B, Adame A, Patrick C, Trejo M, Ubhi K, Rohn TT, Mueller-Steiner S, Seubert P, Barbour R, McConlogue L, Buttini M, et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. Plos One. 6: e19338. PMID 21559417 DOI: 10.1371/Journal.Pone.0019338 |
0.492 |
|
| 2011 |
Patrick C, Crews L, Desplats P, Dumaop W, Rockenstein E, Achim CL, Everall IP, Masliah E. Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. The American Journal of Pathology. 178: 1646-61. PMID 21435449 DOI: 10.1016/J.Ajpath.2010.12.033 |
0.495 |
|
| 2011 |
Crews L, Patrick C, Adame A, Rockenstein E, Masliah E. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease. Cell Death & Disease. 2: e120. PMID 21368891 DOI: 10.1038/Cddis.2011.2 |
0.555 |
|
| 2010 |
Crews L, Adame A, Patrick C, Delaney A, Pham E, Rockenstein E, Hansen L, Masliah E. Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 12252-62. PMID 20844121 DOI: 10.1523/Jneurosci.1305-10.2010 |
0.539 |
|
| 2010 |
Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, Salmon D, Galasko D, Michael S, Savas JN, Yates JR, Glabe C, Masliah E. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. The Febs Journal. 277: 3051-67. PMID 20573181 DOI: 10.1111/J.1742-4658.2010.07719.X |
0.529 |
|
| 2010 |
Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Human Molecular Genetics. 19: R12-20. PMID 20413653 DOI: 10.1093/Hmg/Ddq160 |
0.549 |
|
| 2010 |
Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. Plos One. 5: e9313. PMID 20174468 DOI: 10.1371/Journal.Pone.0009313 |
0.569 |
|
| 2010 |
Crews L, Rockenstein E, Masliah E. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Structure & Function. 214: 111-26. PMID 20091183 DOI: 10.1007/S00429-009-0232-6 |
0.536 |
|
| 2009 |
Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proceedings of the National Academy of Sciences of the United States of America. 106: 13010-5. PMID 19651612 DOI: 10.1073/Pnas.0903691106 |
0.537 |
|
| 2009 |
Crews L, Tsigelny I, Hashimoto M, Masliah E. Role of synucleins in Alzheimer's disease. Neurotoxicity Research. 16: 306-17. PMID 19551456 DOI: 10.1007/S12640-009-9073-6 |
0.561 |
|
| 2009 |
Crews L, Patrick C, Achim CL, Everall IP, Masliah E. Molecular pathology of neuro-AIDS (CNS-HIV). International Journal of Molecular Sciences. 10: 1045-63. PMID 19399237 DOI: 10.3390/Ijms10031045 |
0.464 |
|
| 2009 |
Ubhi K, Rockenstein E, Doppler E, Mante M, Adame A, Patrick C, Trejo M, Crews L, Paulino A, Moessler H, Masliah E. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin. Acta Neuropathologica. 117: 699-712. PMID 19252918 DOI: 10.1007/S00401-009-0505-4 |
0.53 |
|
| 2009 |
Rose JB, Crews L, Rockenstein E, Adame A, Mante M, Hersh LB, Gage FH, Spencer B, Potkar R, Marr RA, Masliah E. Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1115-25. PMID 19176820 DOI: 10.1523/Jneurosci.4220-08.2009 |
0.529 |
|
| 2009 |
Marongiu R, Spencer B, Crews L, Adame A, Patrick C, Trejo M, Dallapiccola B, Valente EM, Masliah E. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. Journal of Neurochemistry. 108: 1561-74. PMID 19166511 DOI: 10.1111/J.1471-4159.2009.05932.X |
0.735 |
|
| 2009 |
Crews L, Spencer B, Masliah E. Role of Aβ degrading enzymes in synaptic plasticity and neurogenesis in Alzheimer's disease Current Hypotheses and Research Milestones in Alzheimer's Disease. 3-12. DOI: 10.1007/978-0-387-87995-6_1 |
0.395 |
|
| 2008 |
Spencer B, Marr RA, Rockenstein E, Crews L, Adame A, Potkar R, Patrick C, Gage FH, Verma IM, Masliah E. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. Bmc Neuroscience. 9: 109. PMID 19014502 DOI: 10.1186/1471-2202-9-109 |
0.506 |
|
| 2008 |
Crews L, Lentz MR, Gonzalez RG, Fox HS, Masliah E. Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. Journal of Neurovirology. 14: 327-39. PMID 18780234 DOI: 10.1080/13550280802132840 |
0.446 |
|
| 2008 |
Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, Yuan JX, Masliah E. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. Plos One. 3: e3135. PMID 18769546 DOI: 10.1371/Journal.Pone.0003135 |
0.565 |
|
| 2008 |
Crews L, Rockenstein E, Masliah E. Biological transgenic mouse models of Alzheimer's disease. Handbook of Clinical Neurology. 89: 291-301. PMID 18631753 DOI: 10.1016/S0072-9752(07)01227-4 |
0.501 |
|
| 2008 |
Doppler E, Rockenstein E, Ubhi K, Inglis C, Mante M, Adame A, Crews L, Hitzl M, Moessler H, Masliah E. Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome. Acta Neuropathologica. 116: 425-37. PMID 18600331 DOI: 10.1007/S00401-008-0407-X |
0.466 |
|
| 2008 |
Crews L, Mizuno H, Desplats P, Rockenstein E, Adame A, Patrick C, Winner B, Winkler J, Masliah E. Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4250-60. PMID 18417705 DOI: 10.1523/Jneurosci.0066-08.2008 |
0.543 |
|
| 2008 |
Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, Spencer B, Masliah E. Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease. Journal of Neurochemistry. 105: 1656-67. PMID 18248604 DOI: 10.1111/J.1471-4159.2008.05254.X |
0.726 |
|
| 2008 |
Kawahara K, Hashimoto M, Bar-On P, Ho GJ, Crews L, Mizuno H, Rockenstein E, Imam SZ, Masliah E. alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease. The Journal of Biological Chemistry. 283: 6979-87. PMID 18195004 DOI: 10.1074/Jbc.M710418200 |
0.545 |
|
| 2008 |
Doppler EE, Rockenstein E, Moessler H, Mante M, Adame A, Crews L, Masliah E. P2-379: Neuroprotective effects of Cerebrolysin on neurofibrillary pathology in APP-transgenic mice that received neuronal gene transfer with AAV2-Tau Alzheimer's & Dementia. 4: T484-T484. DOI: 10.1016/J.Jalz.2008.05.1457 |
0.523 |
|
| 2007 |
Salaria S, Badkoobehi H, Rockenstein E, Crews L, Chana G, Masliah E, Everall IP. Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. Journal of Neurovirology. 13: 496-503. PMID 18097881 DOI: 10.1080/13550280701558616 |
0.437 |
|
| 2007 |
Spencer B, Rockenstein E, Crews L, Marr R, Masliah E. Novel strategies for Alzheimer's disease treatment. Expert Opinion On Biological Therapy. 7: 1853-67. PMID 18034651 DOI: 10.1517/14712598.7.12.1853 |
0.522 |
|
| 2007 |
Rockenstein E, Crews L, Masliah E. Transgenic animal models of neurodegenerative diseases and their application to treatment development Advanced Drug Delivery Reviews. 59: 1093-1102. PMID 17869376 DOI: 10.1016/J.Addr.2007.08.013 |
0.546 |
|
| 2007 |
Kuczenski R, Everall IP, Crews L, Adame A, Grant I, Masliah E. Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat Experimental Neurology. 207: 42-51. PMID 17603040 DOI: 10.1016/J.Expneurol.2007.05.023 |
0.434 |
|
| 2007 |
Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. The Journal of Infectious Diseases. 196: 361-70. PMID 17597450 DOI: 10.1086/519285 |
0.406 |
|
| 2007 |
Tsigelny IF, Bar-On P, Sharikov Y, Crews L, Hashimoto M, Miller MA, Keller SH, Platoshyn O, Yuan JXJ, Masliah E. Dynamics of α-synuclein aggregation and inhibition of pore-like oligomer development by β-synuclein Febs Journal. 274: 1862-1877. PMID 17381514 DOI: 10.1111/J.1742-4658.2007.05733.X |
0.505 |
|
| 2007 |
Rockenstein E, Torrance M, Adame A, Mante M, Bar-on P, Rose JB, Crews L, Masliah E. Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation Journal of Neuroscience. 27: 1981-1991. PMID 17314294 DOI: 10.1523/Jneurosci.4321-06.2007 |
0.543 |
|
| 2007 |
Spencer B, Crews L, Masliah E. Climbing the scaffolds of Parkinson's disease pathogenesis. Neuron. 53: 469-70. PMID 17296545 DOI: 10.1016/J.Neuron.2007.02.002 |
0.527 |
|
| 2007 |
Rockenstein E, Mante M, Adame A, Crews L, Moessler H, Masliah E. Effects of Cerebrolysin™ on neurogenesis in an APP transgenic model of Alzheimer's disease Acta Neuropathologica. 113: 265-275. PMID 17131129 DOI: 10.1007/S00401-006-0166-5 |
0.533 |
|
| 2006 |
Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, Mucke L, Masliah E, Wyss-Coray T. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. The Journal of Clinical Investigation. 116: 3060-9. PMID 17080199 DOI: 10.1172/Jci27341 |
0.514 |
|
| 2006 |
Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology. 67: 1486-9. PMID 17060582 DOI: 10.1212/01.Wnl.0000240066.02404.E6 |
0.409 |
|
| 2006 |
Masliah E, Crews L, Hansen L. Synaptic remodeling during aging and in Alzheimer's disease Journal of Alzheimer's Disease. 9: 91-99. PMID 16914848 DOI: 10.3233/Jad-2006-9S311 |
0.429 |
|
| 2006 |
Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E. Cerebrolysin decreases amyloid-β production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease Journal of Neuroscience Research. 83: 1252-1261. PMID 16511867 DOI: 10.1002/Jnr.20818 |
0.539 |
|
| 2006 |
Webster B, Hansen L, Adame A, Crews L, Torrance M, Thal L, Masliah E. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 65: 142-51. PMID 16462205 DOI: 10.1097/01.Jnen.0000199599.63204.6F |
0.504 |
|
| 2006 |
Rockenstein E, Mante M, Adame A, Crews L, Moessler H, Masliah E. P4-374: Effects of cerebrolysin on neurogenesis in an amyloid precursor protein transgenic animal model of Alzheimer's disease Alzheimer's & Dementia. 2: S628-S628. DOI: 10.1016/J.Jalz.2006.05.2115 |
0.513 |
|
| 2005 |
Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, Hashimoto M, Song D, Iwatsubo T, Tsuboi K, Masliah E. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10689-99. PMID 16291942 DOI: 10.1523/Jneurosci.3527-05.2005 |
0.512 |
|
| 2005 |
Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, Verma IM, Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nature Neuroscience. 8: 1343-9. PMID 16136043 DOI: 10.1038/Nn1531 |
0.538 |
|
| 2005 |
Rockenstein E, Mante M, Alford M, Adame A, Crews L, Hashimoto M, Esposito L, Mucke L, Masliah E. High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer disease. The Journal of Biological Chemistry. 280: 32957-67. PMID 16027115 DOI: 10.1074/Jbc.M507016200 |
0.524 |
|
| 2005 |
Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Seubert P, Lee M, Goldstein J, Chilcote T, Games D, Schenk D. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Neuron. 46: 857-68. PMID 15953415 DOI: 10.1016/J.Neuron.2005.05.010 |
0.544 |
|
| 2005 |
Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, Pfragner R, Schreiner E, Windisch M, Masliah E. Lysosomal pathology associated with α-synuclein accumulation in transgenic models using an eGFP fusion protein Journal of Neuroscience Research. 80: 247-259. PMID 15765523 DOI: 10.1002/Jnr.20446 |
0.556 |
|
| 2005 |
Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound Cerebrolysin™ Journal of Neural Transmission. 112: 269-282. PMID 15657642 DOI: 10.1007/S00702-004-0181-4 |
0.545 |
|
| 2005 |
Masliah E, Hansen L, Adame A, Crews L, Bard F, Lee C, Seubert P, Games D, Kirby L, Schenk D. Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology. 64: 129-31. PMID 15642916 DOI: 10.1212/01.Wnl.0000148590.39911.Df |
0.489 |
|
| 2005 |
Singer O, Marr RA, Rockenstein E, Crews L, Gage FH, Verma IM, Masliah E. 56. Amelioration of Neurodegenerative and Neuropathological Alterations in a Transgenic Model of Alzheimer's Disease: Targeting BACE1 with Small Interfering RNAs Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.084 |
0.544 |
|
| 2005 |
Masliah E, Roberts E, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox H. Corrigendum to “Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis” Journal of Neuroimmunology. 162: 197. DOI: 10.1016/J.Jneuroim.2005.01.013 |
0.39 |
|
| 2004 |
Langford D, Grigorian A, Hurford R, Adame A, Crews L, Masliah E. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons Journal of Neurovirology. 10: 327-337. PMID 15765804 DOI: 10.1080/13550280490520961 |
0.471 |
|
| 2004 |
Hashimoto M, Kawahara K, Bar-On P, Rockenstein E, Crews L, Masliah E. The role of α-synuclein assembly and metabolism in the pathogenesis of Lewy body disease Journal of Molecular Neuroscience. 24: 343-352. PMID 15655259 DOI: 10.1385/Jmn:24:3:343 |
0.514 |
|
| 2004 |
Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis Journal of Neuroimmunology. 157: 163-175. PMID 15579294 DOI: 10.1016/J.Jneuroim.2004.08.026 |
0.477 |
|
| 2004 |
Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Therapy. 11: 1713-23. PMID 15483670 DOI: 10.1038/Sj.Gt.3302349 |
0.526 |
|
| 2004 |
Crews L, Wyss-Coray T, Masliah E. Insights into the pathogenesis of hydrocephalus from transgenic and experimental animal models. Brain Pathology (Zurich, Switzerland). 14: 312-6. PMID 15446587 DOI: 10.1111/J.1750-3639.2004.Tb00070.X |
0.473 |
|
| 2004 |
Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E. β-synuclein regulates Akt activity in neuronal cells: A possible mechanism for neuroprotection in Parkinson's disease Journal of Biological Chemistry. 279: 23622-23629. PMID 15026413 DOI: 10.1074/Jbc.M313784200 |
0.535 |
|
| 2004 |
Rockenstein E, Mante M, Adame A, Crews L, Laurrea G, Masliah E. P1-296 Neuroprotective effects of compounds regulating the GSK3β pathway in a THY1-amyloid precursor protein transgenic animal model of Alzheimer's disease Neurobiology of Aging. 25: S180. DOI: 10.1016/S0197-4580(04)80609-2 |
0.513 |
|
| 2003 |
Hashimoto M, Rockenstein E, Crews L, Masliah E. Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases Neuromolecular Medicine. 4: 21-35. PMID 14528050 DOI: 10.1385/Nmm:4:1-2:21 |
0.564 |
|
| Show low-probability matches. |